Characteristics and management of olecranon or prepatellar septic bursitis

Affiliations

¹ Department of Rheumatology, CHU Lille, Université de Lille, F-59000 Lille, France.
² Department of Rheumatology, Centre Hospitalier de Beuvry, Béthune, France.
³ Department of Rheumatology, Saint-Philibert Catholic Hospital, University of Lille, Lomme, France.
⁴ Department of Infectious Diseases, Centre Hospitalier de Tourcoing, France.
⁵ Rheumatology Department, Centre Hospitalier Régional d'Orléans, F-4067 Orleans, France. Electronic address: carine.salliot@chr-orleans.fr.

Comment

K Nguyen et al. Infect Dis Now. 2023 Mar.

. 2023 Mar;53(2):104652.

doi: 10.1016/j.idnow.2023.104652. Epub 2023 Jan 25.

¹ Department of Rheumatology, CHU Lille, Université de Lille, F-59000 Lille, France.
² Department of Rheumatology, Centre Hospitalier de Beuvry, Béthune, France.
³ Department of Rheumatology, Saint-Philibert Catholic Hospital, University of Lille, Lomme, France.
⁴ Department of Infectious Diseases, Centre Hospitalier de Tourcoing, France.
⁵ Rheumatology Department, Centre Hospitalier Régional d'Orléans, F-4067 Orleans, France. Electronic address: carine.salliot@chr-orleans.fr.

No abstract available

Comment on

Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study.
Charret L, Bart G, Hoppe E, Dernis E, Cormier G, Boutoille D, Le Goff B, Darrieutort-Laffite C. Charret L, et al. J Antimicrob Chemother. 2021 Oct 11;76(11):3029-3032. doi: 10.1093/jac/dkab265. J Antimicrob Chemother. 2021. PMID: 34293150